1 Min Read
Dec 6 (Reuters) - Suven Life Sciences Ltd:
* PATENTS CORRESPONDS TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES Source text - bit.ly/2AUMl7N Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.